Montelukast Sodium Tablet, Chewable
Product Images NDC 29300-221

7 FDA label images from Unichem Pharmaceuticals (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 29300-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)

Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)
A line graph showing change in height (cm) over weeks on treatment for montelukast sodium 5 mg, beclomethasone 336 mcg, and placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height in centimeters. Lines illustrate growth trends among the three groups during the study period.*
FDA Label Image

Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)

Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)
Chemical structure of montelukast sodium, showing its molecular framework including aromatic rings, a chlorine atom, sulfur-containing ring, and sodium carboxylate group.*
FDA Label Image

Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)

Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)
A line graph showing the mean percent change from baseline over 15 weeks of treatment comparing placebo and montelukast sodium. The x-axis represents weeks in treatment, and the y-axis shows the mean percent change. Montelukast sodium shows a higher mean percent increase compared to placebo, with values peaking around 12 weeks before a decline during a washout period.*
FDA Label Image

Image (18422beb 7f97 43aa 8f64 1d30aa8b07f7 907 2)

FDA Label Image

Montelukast Sodium Tablets Usp, 10 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 04)

Montelukast Sodium Tablets Usp, 10 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 04)
Montelukast Sodium Tablets, USP 10 mg chewable tablets label from Unichem Pharmaceuticals (USA), Inc. The label shows the NDC number 29300-220-13 and specifies packaging of 30 tablets. It includes storage instructions, a barcode, and manufacturing information for Unichem Laboratories Ltd., India, and Unichem Pharmaceuticals (USA), Inc., New Jersey.*
FDA Label Image

Montelukast Sodium Chewable Tablets Usp, 5 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 05)

Montelukast Sodium Chewable Tablets Usp, 5 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 05)
Montelukast Sodium CHEWABLE Tablets USP 5 mg for pediatric patients 6-14 years, labeled as chewable tablets with 30 count, manufactured by Unichem Laboratories Ltd. and labeled for Unichem Pharmaceuticals (USA), Inc. The label includes dosage information, storage instructions, and a warning for phenylketonurics. The NDC is 29300-222-13.*
FDA Label Image

Montelukast Sodium Chewable Tablets Usp, 4 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 06)

Montelukast Sodium Chewable Tablets Usp, 4 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 06)
Montelukast Sodium chewable tablets USP 4 mg in a package containing 30 tablets. The label shows it is for pediatric patients 2 to 5 years old, manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. It includes storage instructions and phenylketonurics warning regarding phenylalanine content.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.